Try
MERIT MEDICAL SYSTEMS INC
MMSIUnited States
101 filed reports · 661 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
101 reports · Jun 2011 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 264 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 46 | 8,303 | Jun 2011 to Jun 2026 |
| Current · 8-KSEC EDGAR | 38 | 261 | Dec 2011 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 15 | 9,159 | Dec 2011 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 2 | 2 | Dec 2019 to Dec 2024 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 30, 2026 | 425 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 30, 2026 | 1 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | Apr 30, 2026 | 248 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | Apr 30, 2026 | 4 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 24, 2026 | 1,203 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 24, 2026 | 4 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 30, 2025 | 4 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 30, 2025 | 322 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 30, 2025 | 210 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 30, 2025 | 4 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 20, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | Apr 24, 2025 | 211 | Open |
Financial data
661 concepts · 17,725 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial610 concepts · 15,518 facts · Mar 2009 to Jul 2026
- Cash and cash equivalents at carrying value83 · Dec 2009 to Jun 2026
- Gross profit (US GAAP)83 · Dec 2009 to Jun 2026
- Income tax expense benefit83 · Dec 2009 to Jun 2026
- Revenue83 · Dec 2009 to Jun 2026
- Net income loss82 · Dec 2009 to Jun 2026
- Nonoperating income expense82 · Dec 2009 to Jun 2026
- Operating expenses (US GAAP)82 · Dec 2009 to Jun 2026
- Operating income loss82 · Dec 2009 to Jun 2026
- Other nonoperating income expense82 · Dec 2009 to Jun 2026
- Selling general and administrative expense82 · Dec 2009 to Jun 2026
- Adjustments to reconcile net income loss to cash provided by used in operating activities81 · Dec 2009 to Jun 2026
- Capital expenditures incurred but not yet paid81 · Dec 2009 to Jun 2026
- Depreciation depletion and amortization81 · Dec 2009 to Jun 2026
- Income taxes paid net81 · Dec 2009 to Jun 2026
- Increase decrease in accounts payable trade81 · Dec 2009 to Jun 2026
- Increase decrease in accounts receivable81 · Dec 2009 to Jun 2026
- Increase decrease in accrued income taxes payable81 · Dec 2009 to Jun 2026
- Increase decrease in accrued liabilities81 · Dec 2009 to Jun 2026
- Increase decrease in deferred compensation81 · Dec 2009 to Jun 2026
- Increase decrease in income taxes receivable81 · Dec 2009 to Jun 2026
- Increase decrease in inventories81 · Dec 2009 to Jun 2026
- Increase decrease in other operating liabilities81 · Dec 2009 to Jun 2026
- Increase decrease in other receivables81 · Dec 2009 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets81 · Dec 2009 to Jun 2026
Segment23 concepts · 1,739 facts · Dec 2009 to Jun 2026
- Revenue1,226 · Dec 2009 to Jun 2026
- Operating income loss156 · Dec 2009 to Dec 2025
- Depreciation depletion and amortization52 · Dec 2009 to Dec 2025
- Payments to acquire property plant and equipment32 · Dec 2009 to Dec 2023
- Total Assets29 · Dec 2010 to Dec 2023
- Cardiovascular28 · Mar 2020 to Dec 2025
- Cost depreciation amortization and depletion28 · Dec 2022 to Jun 2026
- Cost of goods and service excluding depreciation depletion and amortization28 · Dec 2022 to Jun 2026
- Research and development expense28 · Dec 2022 to Jun 2026
- Selling general and administrative expense24 · Dec 2022 to Dec 2025
- Operating expenses (US GAAP)22 · Dec 2009 to Dec 2019
- Other cost and expense operating17 · Dec 2022 to Jun 2026
- Goodwill14 · Sep 2024 to Dec 2025
- Goodwill impairment loss10 · Dec 2009 to Dec 2012
- Endoscopy Segment8 · Dec 2010 to Dec 2013
- Goodwill acquired during period8 · Dec 2023 to Dec 2025
- Goodwill foreign currency translation gain loss8 · Dec 2023 to Dec 2025
- General and administrative expense (US GAAP)4 · Mar 2025 to Jun 2026
- Income tax expense benefit4 · Mar 2025 to Jun 2026
- Net income loss4 · Mar 2025 to Jun 2026
- Nonoperating income expense4 · Mar 2025 to Jun 2026
- Selling and marketing expense (US GAAP)4 · Mar 2025 to Jun 2026
- Impairment of intangible assets finitelived1 · Sep 2020
Guidance23 concepts · 264 facts · Feb 2012 to Jul 2026
- EPS (Diluted) Guidance66 · Feb 2012 to Apr 2026
- Revenue Guidance62 · Feb 2012 to Jul 2026
- Revenue Growth Guidance26 · Oct 2012 to Feb 2023
- EPS (Diluted) Guidance (Adjusted (non-GAAP))24 · Oct 2016 to Feb 2023
- Gross Margin Guidance18 · Jul 2017 to Oct 2019
- Net Income Guidance14 · Oct 2020 to Feb 2023
- Net Income Guidance (Adjusted (non-GAAP))14 · Oct 2020 to Feb 2023
- Gross Margin Guidance (Adjusted (non-GAAP))6 · Oct 2017 to Jul 2019
- Revenue Growth Guidance (Constant currency)6 · Oct 2021 to Feb 2023
- Revenue Growth Guidance (Adjusted (non-GAAP))4 · Feb 2019
- Capital Expenditures Guidance2 · Jul 2026
- Effective Tax Rate Guidance2 · Feb 2019
- EPS (Diluted) Guidance (Pre-Coronavirus)2 · Feb 2020
- EPS (Diluted) Guidance (Pre-Coronavirus; Adjusted (non-GAAP))2 · Feb 2020
- Net Income Growth Guidance2 · Feb 2019
- Operating Margin Guidance (Adjusted (non-GAAP))2 · Jul 2022 to Feb 2023
- Operating Margin Guidance (Pre-Coronavirus)2 · Feb 2020
- Operating Margin Guidance (Pre-Coronavirus; Adjusted (non-GAAP))2 · Feb 2020
- Revenue Growth Guidance (excluding the impact of divestitures and product sales that uniquely benefitted from pandemic-related demand trends in 2020; Constant currency)2 · Oct 2021
- Revenue Growth Guidance (Organic, constant currency)2 · Jul 2022 to Feb 2023
- Revenue Guidance (Pre-Coronavirus)2 · Feb 2020
- Free Cash Flow Guidance1 · Feb 2023
- Free Cash Flow Guidance (Adjusted (non-GAAP))1 · Jul 2022
Geography4 concepts · 153 facts · Dec 2009 to Jun 2026
- Revenue117 · Dec 2009 to Jun 2026
- Property, Plant & Equipment, Net24 · Dec 2018 to Dec 2025
- Non-US7 · Dec 2014 to Dec 2018
- Defined contribution plan cost recognized5 · Dec 2013 to Dec 2017
Product1 concepts · 51 facts · Dec 2009 to Jun 2026
- Revenue51 · Dec 2009 to Jun 2026
Segments
1,943 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments7 members · 1,739 facts
- Cardiovascular1,224 · Dec 2010 to Dec 2025
- Endoscopy414 · Dec 2009 to Dec 2025
- Single Reportable40 · Mar 2025 to Jun 2026
- Endoscopy segment21 · Dec 2010 to Dec 2025
- Cardiovascular segment20 · Dec 2011 to Dec 2025
- Reportable Segments18 · Dec 2009 to Dec 2011
- Reportable segments2 · Dec 2010 to Dec 2011
Statement geographicalsrt:StatementGeographicalAxis6 members · 129 facts
- Non Us50 · Dec 2016 to Jun 2026
- US47 · Dec 2016 to Jun 2026
- CN8 · Dec 2017 to Dec 2024
- Ie8 · Dec 2018 to Dec 2025
- Us8 · Dec 2018 to Dec 2025
- Non usexcluding ireland8 · Dec 2018 to Dec 2025
Product or servicesrt:ProductOrServiceAxis13 members · 30 facts
- Foundational4 · Mar 2025 to Jun 2026
- Therapeutic4 · Mar 2025 to Jun 2026
- Foundational Access2 · Jun 2025 to Jun 2026
- Foundational Original Equipment Manufacturer2 · Jun 2025 to Jun 2026
- Foundational Procedural Solutions2 · Jun 2025 to Jun 2026
- Foundational Vascular Intervention2 · Jun 2025 to Jun 2026
- Product And Service Other2 · Jun 2025 to Jun 2026
- Therapeutic Cardiac Therapies2 · Jun 2025 to Jun 2026
- Therapeutic Endoscopy2 · Jun 2025 to Jun 2026
- Therapeutic Oncology2 · Jun 2025 to Jun 2026
- Therapeutic Original Equipment Manufacturer2 · Jun 2025 to Jun 2026
- Therapeutic Renal Therapies2 · Jun 2025 to Jun 2026
- Therapeutic Vascular Intervention2 · Jun 2025 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis3 members · 24 facts
- Non Us16 · Dec 2013 to Mar 2018
- Foreign Sales6 · Dec 2009 to Dec 2014
- US2 · Mar 2017 to Mar 2018
Product or serviceus-gaap:ProductOrServiceAxis7 members · 21 facts
- Catheters3 · Dec 2009 to Dec 2011
- Custom Kit And Procedures Trays3 · Dec 2009 to Dec 2011
- Embolization Devices3 · Dec 2009 to Dec 2011
- Endoscopy Devices3 · Dec 2009 to Dec 2011
- Inflation Devices3 · Dec 2009 to Dec 2011
- Stand Alone Devices3 · Dec 2009 to Dec 2011
- Total Cardiovascular3 · Dec 2009 to Dec 2011
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.